These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15767513)

  • 1. Contribution of aging to the severity of different motor signs in Parkinson disease.
    Levy G; Louis ED; Cote L; Perez M; Mejia-Santana H; Andrews H; Harris J; Waters C; Ford B; Frucht S; Fahn S; Marder K
    Arch Neurol; 2005 Mar; 62(3):467-72. PubMed ID: 15767513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
    Goberman AM
    Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people.
    Louis ED; Tang MX; Schupf N; Mayeux R
    Arch Neurol; 2005 Feb; 62(2):297-302. PubMed ID: 15710859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses.
    Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K
    Mov Disord; 2002 May; 17(3):513-7. PubMed ID: 12112199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor impairment in PD: relationship to incident dementia and age.
    Levy G; Tang MX; Cote LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
    Neurology; 2000 Aug; 55(4):539-44. PubMed ID: 10953188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the structure of motor symptoms of Parkinson's disease.
    Stochl J; Boomsma A; Ruzicka E; Brozova H; Blahus P
    Mov Disord; 2008 Jul; 23(9):1307-12. PubMed ID: 18464275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mokken scale analysis of the UPDRS: dimensionality of the Motor Section revisited.
    Stochl J; Boomsma A; van Duijn M; Brozová H; Růzická E
    Neuro Endocrinol Lett; 2008 Feb; 29(1):151-8. PubMed ID: 18283252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
    Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
    Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-minute walk distance in persons with Parkinson disease: a hierarchical regression model.
    Falvo MJ; Earhart GM
    Arch Phys Med Rehabil; 2009 Jun; 90(6):1004-8. PubMed ID: 19480877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
    Sung YH; Chung SJ; Kim SR; Lee MC
    Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation.
    Taylor Tavares AL; Jefferis GS; Koop M; Hill BC; Hastie T; Heit G; Bronte-Stewart HM
    Mov Disord; 2005 Oct; 20(10):1286-98. PubMed ID: 16001401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.